Drugs / GSK615915A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00400660 | Nov 2005 → Jul 2006 | bronchial disorder | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK615915A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00400660 ↗ |
| Route | Inhaled | “GSK615915A inhaler will be given” NCT00400660 ↗ |